Allergy News: Monoclonal Antibody Improves Cat Allergen Immunotherapy

Findings published in the Journal of Allergy and Clinical Immunology

Tuesday, October 11, 2022 Monoclonal Antibody Improves Cat Allergen Immunotherapy Giving the monoclonal antibody tezepelumab plus cat allergy shots to people with allergic rhinitis caused by cat allergens safely provided better, faster long-lasting symptom relief than allergy shots alone, a NIAID-supported study has found. The findings were published Monday in the Journal of Allergy and Clinical Immunology. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107